John P Longenecker is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies and anti-inflammatory proteins. With a total of four patents to his name, Longenecker's work has had a meaningful impact on medical research and applications.

Latest Patents

Among his latest patents, Longenecker has developed antibodies for human phospholipase inhibitory protein (hPIP). These antibodies react with the human phospholipase inhibitory protein/apolipoprotein AIV complex and hPIP, providing valuable tools for research and potential therapeutic applications. Additionally, he has created a recombinant expression system for human anti-inflammatory phospholipase. This innovation allows for the cloning and expression of the gene encoding hPIP, enabling the production of an anti-inflammatory protein in practical quantities using recombinant techniques.

Career Highlights

Throughout his career, Longenecker has worked with several prominent companies, including Scios Nova, Inc. and California Biotechnology Inc. His experience in these organizations has contributed to his expertise in biotechnology and patent development.

Collaborations

Longenecker has collaborated with notable coworkers such as Lorin K Johnson and Richard Ennis. These partnerships have likely enhanced his research and innovation efforts in the field.

Conclusion

John P Longenecker's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical research and therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com